{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:42Z","timestamp":1753890582782,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Response rates for cardiac resynchronization therapy (CRT) in patients without intrinsic left bundle-branch block (LBBB) morphology are poor.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> We sought to develop a nomogram model to predict response to CRT in patients without intrinsic LBBB.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We searched electronic health records for patients without intrinsic LBBB who underwent CRT at Mayo Clinic. Logistic regression and Cox proportional hazards regression analysis were performed for the odds of response to CRT and risk of death, respectively. Results were used to develop the nomogram model.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> 761 patients without intrinsic LBBB were identified. Six months after CRT, 47.8% of patients demonstrated improvement of left ventricular ejection fraction by more than 5%. The 1-, 3-, and 5-year survival rates were 95.9, 82.4, and 66.70%, respectively. Patients with CRT upgrade from pacemaker [odds ratio (OR), 1.67 (95% CI, 1.05\u20132.66)] or atrioventricular node (AVN) ablation [OR, 1.69 (95% CI, 1.09\u20132.64)] had a greater odds of CRT response than those patients who had new implant, or who did not undergo AVN ablation. Patients with right bundle-branch block had a low response rate (39.2%). Patients undergoing AVN ablation had a lower mortality rate than those without ablation [hazard ratio, 0.65 (95% CI, 0.46\u20130.91)]. Eight clinical variables were automatically selected to build a nomogram model and predict CRT response. The model had an area under the receiver operating characteristic curve of 0.71 (95% CI, 0.63\u20130.78).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Among patients without intrinsic LBBB undergoing CRT, upgrade from pacemaker and AVN ablation were favorable factors in achieving CRT response and better long-term outcomes.<\/jats:p>","DOI":"10.3389\/fcvm.2021.760195","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T05:15:52Z","timestamp":1635743752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Better CRT Response in Patients Who Underwent Atrioventricular Node Ablation or Upgrade From Pacemaker: A Nomogram to Predict CRT Response"],"prefix":"10.3389","volume":"8","author":[{"given":"Pei-Lin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva K.","family":"Mulpuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek J.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Mei","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial","volume":"289","author":"Young","year":"2003","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0735-1097(02)01895-8","article-title":"Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay","volume":"39","author":"Auricchio","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jacc.2012.11.007","article-title":"2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american college of cardiology foundation\/american heart association task force on practice guidelines and the heart rhythm society","volume":"61","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e007316","DOI":"10.1161\/CIRCEP.119.007316","article-title":"Machine learning prediction of response to cardiac resynchronization therapy","volume":"12","author":"Feeny","year":"2019","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrcardio.2014.67","article-title":"Strategies to improve cardiac resynchronization therapy","volume":"11","author":"Vernooy","year":"2014","journal-title":"Nat Rev Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jcmg.2016.08.015","article-title":"Long-term outcome after CRT in the presence of mechanical dyssynchrony seen with chronic RV pacing or intrinsic LBBB","volume":"10","author":"Stankovic","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11886-017-0929-8","article-title":"Does cardiac resynchronization therapy benefit patients with non-left bundle branch block prolonged QRS patterns?","volume":"19","author":"Belkin","year":"2017","journal-title":"Curr Cardiol Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcmg.2009.12.014","article-title":"Comparative mechanical activation mapping of RV pacing to LBBB by 2D and 3D speckle tracking and association with response to resynchronization therapy","volume":"3","author":"Tanaka","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/heartjnl-2014-306811","article-title":"Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials","volume":"101","author":"Cunnington","year":"2015","journal-title":"Heart."},{"key":"B20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","article-title":"Nomogram for preoperative estimation of microvascular invasion risk in Hepatitis B virus-related hepatocellular carcinoma within the milan criteria","volume":"151","author":"Lei","year":"2016","journal-title":"JAMA Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). developed in collaboration with the european heart rhythm association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0735-1097(85)80335-1","article-title":"Criteria for intraventricular conduction disturbances and pre-excitation world health organizational\/international society and federation for cardiology task force Ad Hoc","volume":"5","author":"Willems","year":"1985","journal-title":"J Am Coll Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users' guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jce.13131","article-title":"Effect of pr interval on outcomes following cardiac resynchronization therapy: a secondary analysis of the COMPANION trial","volume":"28","author":"Lin","year":"2017","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","article-title":"Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT)","volume":"123","author":"Zareba","year":"2011","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/eurheartj\/eht123","article-title":"QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy","volume":"34","author":"Kandala","year":"2013","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCEP.113.000628","article-title":"Does cardiac resynchronization therapy benefit patients with right bundle branch block: cardiac resynchronization therapy has a role in patients with right bundle branch block","volume":"7","author":"Auricchio","year":"2014","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1016\/j.jacc.2019.04.025","article-title":"Cardiac resynchronization defibrillator therapy for nonspecific intraventricular conduction delay versus right bundle branch block","volume":"73","author":"Kawata","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.hrthm.2009.07.009","article-title":"Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival","volume":"6","author":"Wokhlu","year":"2009","journal-title":"Heart Rhythm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.110.956011","article-title":"Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in medicare patients","volume":"122","author":"Bilchick","year":"2010","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/eurheartj\/ehr470","article-title":"Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch block","volume":"33","author":"Leong","year":"2012","journal-title":"Eur Heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.hrthm.2010.02.011","article-title":"Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy","volume":"7","author":"Dong","year":"2010","journal-title":"Heart Rhythm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","article-title":"A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1161\/CIR.0000000000000720","article-title":"2018 ACC\/AHA\/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ehj.2004.04.023","article-title":"Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial","volume":"25","author":"Sharma","year":"2004","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.760195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T05:15:54Z","timestamp":1635743754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.760195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2021.760195"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.760195","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"760195"}}